Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Microtubule Stabilizer (BMS-241027) in Healthy Females
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Aug 2013
Price :
$35
*
At a glance
- Drugs BMS 241027 (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- 16 Aug 2013 New trial record
- 16 Jul 2013 Results presented at the 2013 Alzheimer's Association International Conference .